Find clinical trials for Pancreatic Cancer in Louisville, KY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near Louisville, KY, USA:
Subjects will be offered the opportunity to participate in a randomized, controlled, 2-arm, unblinded multicenter trial (RCT). There will be 2 study...
Phase 3
Louisville, Kentucky, United States and 5 other locations
Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...
Phase 2
Louisville, Kentucky, United States and 135 other locations
phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety pr...
Phase 1
Louisville, Kentucky, United States and 70 other locations
. Zolbetuximab attaches to a protein called CLDN18.2 found at high levels on the surface of the cancer tumor. This switches on the ...
Phase 1
Louisville, Kentucky, United States and 4 other locations
This trial will study tisotumab vedotin to find out whether it is an effective treatment alone or with other anticancer drugs for certain solid tumors...
Phase 2
Louisville, Kentucky, United States and 71 other locations
This study is open to adults with advanced cancer in the biliary tract, pancreas, lung, or bladder. This is a study for people for ...
Phase 2
Louisville, Kentucky, United States and 59 other locations
The purpose of this study is to provide continued supply of ruxolitinib alone, ruxolitinib plus background cancer therapy, or background cancer...
Phase 2
Louisville, Kentucky, United States and 8 other locations
of AZD0901 as monotherapy and in combination with anti-cancer agents in participants with locally advanced unresectable or metastatic solid ...
Phase 2
Louisville, Kentucky, United States and 48 other locations
A Phase 1 Dose Escalation and Expansion Study of IMP7068 Monotherapy in Advanced Solid Tumors...
Phase 1
Louisville, Kentucky, United States and 15 other locations
of SNS-101, a novel anti VISTA IgG1 monoclonal antibody as monotherapy or in combination with cemiplimab in patients with advanced solid tumors...
Phase 1, Phase 2
Louisville, Kentucky, United States and 10 other locations
Clinical trials
Research sites
Resources
Legal